BFH vs BRK-B

BFH exhibits a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. The stock appears undervalued with a P/E of 7.19 versus sector average of 21.34 and trades below both the Graham Number ($124.61) and intrinsic value estimate ($282.31), suggesting significant upside potential. Strong earnings growth (YoY EPS +118.5%, Earnings Growth YoY 9703.90%) and consistent analyst target support ($80.07) contrast with deteriorating technical trend (0/100) and lack of insider activity. Key risks include incomplete financial data (missing debt, cash, EV metrics), volatile earnings surprises, and declining short-term price momentum.

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.